National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health.


Journal

The Psychiatric clinics of North America
ISSN: 1558-3147
Titre abrégé: Psychiatr Clin North Am
Pays: United States
ID NLM: 7708110

Informations de publication

Date de publication:
12 2023
Historique:
medline: 27 10 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

The wide and effective dissemination of research findings is crucial to the mission of the National Institute on Drug Abuse (NIDA). This article describes NIDA dissemination efforts and resources that are available to inform clinicians, teens, families, and educators about youth and substance use. Resources that are available include content addressing facts about youth drug use, trends in use, and stigma, in addition to substance use disorder (SUD) prevention and treatment. Information is provided about resources such as infographics, research-based practice guides, training, educational events, and online videos. How input is solicited to inform dissemination efforts is described and future directions for NIDA's dissemination efforts are outlined.

Identifiants

pubmed: 37879839
pii: S0193-953X(23)00034-5
doi: 10.1016/j.psc.2023.03.009
pii:
doi:

Substances chimiques

N-nitrosoiminodiacetic acid 25081-31-6

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

789-799

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Disclosure Drs G.A. Subramaniam and K. Huntley, Mss Q. Blackeney, M. Corbin, and J. Linton are employees of the National Institute on Drug Abuse. Dr G.A. Subramaniam, Mss M. Corbin, J. Linton, and Q. Blackeney have no other conflicts to report. Dr K. Huntley’s spouse is eligible for a defined benefit plan through Pfizer from previous employment. L. Nolan is an employee of JBS International and has no conflicts to report. Dr T. Mandell and Ms K. Crenshaw are employees of the Bizzell Group and have no conflicts to report.

Auteurs

Geetha A Subramaniam (GA)

Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA. Electronic address: geetha.subramaniam@nih.gov.

Laura Nolan (L)

JBS International, Inc., 5515 Security Lane, North Bethesda, MD 20852, USA.

Kristen Huntley (K)

Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.

Michelle Corbin (M)

Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.

Kenyatta Crenshaw (K)

The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA.

Todd Mandell (T)

The Bizzell Group LLC, 8201 Corporate Drive, 9th Floor, New Carrollton, MD 20785, USA.

Janet Linton (J)

Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA; Center for Tobacco Products, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Quandra Blackeney (Q)

Center for the Clinical Trials Network, National Institute on Drug Abuse, 3WFN RM 09A54 MSC 6022, 301 North Stonestreet Avenue, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH